Sinovac Biotech (SVA) Liabilities and Shareholders Equity (2010 - 2025)
Sinovac Biotech (SVA) posted Liabilities and Shareholders Equity of $8.54 billion for Q4 2025, down 30.8% from $12.34 billion a year earlier.
Powered by 
Analysis
Sinovac Biotech (SVA) Liabilities and Shareholders Equity (2010 - 2025) Analysis & Trends
Since Q4 2010, Sinovac Biotech has reported Liabilities and Shareholders Equity for 16 quarters.
- Annual Liabilities and Shareholders Equity has declined for four consecutive years, though with a five-year compound annual growth rate of 35.1% (FY2020 to FY2025).
- In prior years, Sinovac Biotech's Liabilities and Shareholders Equity was $12.34 billion in FY2024 (-9.4%), $13.61 billion in FY2023 (-3.0%), $14.03 billion in FY2022 (-16.3%) and $16.76 billion in FY2021 (+781.4%).
- The Q4 2025 figure stands as the lowest quarterly Liabilities and Shareholders Equity since Q4 2020.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Liabilities and Shareholders Equity (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,165.22 Bn | 1,133.81 Bn | 19.71 Bn | 142.28 Bn |
| 2 | Johnson & Johnson | 646.28 Bn | 566.14 Bn | 17.30 Bn | 197.43 Bn |
| 3 | AbbVie | 503.17 Bn | 476.28 Bn | 12.70 Bn | 135.12 Bn |
| 4 | Merck | 365.23 Bn | 319.60 Bn | 12.21 Bn | 129.80 Bn |
| 5 | Novartis Ag | 302.66 Bn | 266.65 Bn | 11.24 Bn | 122.03 Bn |
| 6 | Astrazeneca | 267.39 Bn | 241.08 Bn | 12.86 Bn | 115.83 Bn |
| 7 | Amgen | 241.61 Bn | 197.01 Bn | 7.24 Bn | 95.64 Bn |
| 8 | Gilead Sciences | 194.67 Bn | 168.86 Bn | 6.22 Bn | 49.36 Bn |
| 9 | Pfizer | 172.91 Bn | 119.55 Bn | 10.94 Bn | 201.13 Bn |
| 10 | Sinovac Biotech | 464.94 Mn | -35.05 Bn | - | 8.54 Bn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2025 | 8.54 Bn |
| Dec 31, 2024 | 12.34 Bn |
| Dec 31, 2023 | 13.61 Bn |
| Dec 31, 2022 | 14.03 Bn |
| Dec 31, 2021 | 16.76 Bn |
| Dec 31, 2020 | 1.90 Bn |
| Dec 31, 2019 | 452.30 Mn |
| Dec 31, 2018 | 369.78 Mn |
| Dec 31, 2017 | 299.22 Mn |
| Dec 31, 2016 | 211.36 Mn |
| Dec 31, 2015 | 202.93 Mn |
| Dec 31, 2014 | 238.53 Mn |
| Dec 31, 2013 | 240.69 Mn |
| Dec 31, 2012 | 208.76 Mn |
| Dec 31, 2011 | 215.91 Mn |
| Dec 31, 2010 | 214.36 Mn |
API Access
Sinovac Biotech Liabilities and Shareholders Equity API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SVA&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "liabilities-and-shareholders-equity", "ticker": "SVA", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=liabilities-and-shareholders-equity&ticker=SVA&period=max&api_key=YOUR_API_KEY");
const data = await res.json();